Moody's Q2 2026 Beats, But Valuation Constraints Limit Upside

What happened

Moody's reported exceptional Q2 2026 results, driven by continued strength in debt issuance and its analytics business, prompting an updated full-year outlook. The earnings release highlights robust revenue and earnings growth, though specific figures were not provided. The company's high-margin MIS and MA segments continue to benefit from favorable issuance conditions and subscription momentum. However, the stock trades at a substantial premium—over 40x earnings and ~170% above our conservative DCF—leaving little room for error. The strong results reinforce the underlying business quality but do not alter our view that the current valuation fully prices in optimistic assumptions.

Implication

The exceptional Q2 results confirm Moody’s powerful earnings momentum from a robust issuance cycle and resilient analytics demand. However, the market already prices in sustained high growth, with the stock at ~41x P/E and ~29x EV/EBITDA—far above our intrinsic value estimate of ~$189/share. Any slowdown in issuance or unexpected regulatory/AI disruption could trigger a significant de-rating. For long-term holders, this is a time to trim or hold, not add; for new investors, patience is warranted for a better entry point. The business quality remains extraordinary, but the risk/reward is unfavorable at current levels.

Thesis delta

The Q2 beat and raised outlook provide near-term positive momentum, but they do not address the structural overvaluation highlighted in our master report. The underlying narrative of cyclical dependency and premium pricing remains intact. We maintain our POTENTIAL SELL stance, as the earnings strength only further validates the high bar already embedded in the stock price.